H-CLAVEEVSLRK-OH
Ref. 3D-PP47138
1mg | 248,00 € | ||
10mg | 292,00 € | ||
100mg | 481,00 € |
Produktinformation
Peptide H-CLAVEEVSLRK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CLAVEEVSLRK-OH include the following: Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis W Zhang , JM Navenot, NM Frilot, N Fujii - Molecular pharmacology, 2007 - ASPEThttps://molpharm.aspetjournals.org/content/72/5/1310.short Monitoraggio delle risposte T-cellulari specifiche contro la proteina NPM1 mutata in pazienti con leucemia acuta mieloide con mutazione di NPM1: correlazione con l' S TEDDE - 2017 - morethesis.unimore.ithttps://morethesis.unimore.it/theses/available/etd-09192017-142541/ Genetic alterations and checkpoint expression: mechanisms and models for drug discovery S Ding, S Li, S Zhang, Y Li - Regulation of Cancer Immune Checkpoints , 2020 - Springerhttps://link.springer.com/chapter/10.1007/978-981-15-3266-5_10 HLA class I genotype Is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated acute myeloid leukemia R Narayan, A Niroula , T Wang, M Kuxhausen - and cellular therapy, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2666636723012046 A"grappling hook"Â interaction balances self-assembly and chaperone activity of Nucleophosmin 1 M Saluri , A Leppert , GV Gese , C Sahin , D Lama - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.09.29.510028.abstract A"grappling hook"Â interaction connects self-assembly and chaperone activity of Nucleophosmin 1 M Saluri , A Leppert , GV Gese , C Sahin , D Lama - PNAS , 2023 - academic.oup.comhttps://academic.oup.com/pnasnexus/article-abstract/2/2/pgac303/6973215 The interplay between the genetic and immune landscapes of AML: mechanisms and implications for risk stratification and therapy LM Mendez , RR Posey, PP Pandolfi - Frontiers in Oncology, 2019 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2019.01162/full Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid Leukemia G Koutsoumpli, DI van der Lee, NC Groenland - Blood, 2022 - ashpublications.orghttps://ashpublications.org/blood/article/140/Supplement%201/10243/489588 Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia F Forghieri, G Riva, I Lagreca, P Barozzi - International Journal of , 2021 - mdpi.comhttps://www.mdpi.com/1422-0067/22/17/9159 Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia F Forghieri, G Riva, I Lagreca, P Barozzi, D Vallerini - Oncotarget, 2019 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368236/ Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia DI van der Lee, RM Reijmers - The Journal of , 2019 - Am Soc Clin Investighttps://www.jci.org/articles/view/97482 Mutated NPM1 as target for immunotherapy of acute myeloid leukemia DI Van Der Lee, HM Bijen, RS Hagedoorn - Blood, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006497119806857 An HLA-A* 11: 01-binding neoantigen from mutated NPM1 as target for TCR gene therapy in AML DI van der Lee, G Koutsoumpli, RM Reijmers - Cancers, 2021 - mdpi.comhttps://www.mdpi.com/2072-6694/13/21/5390 Could Targeting NPM1c+ Misfolding Be a Promising Strategy for Combating Acute Myeloid Leukemia? D Florio, D Marasco - International Journal of Molecular Sciences, 2024 - mdpi.comhttps://www.mdpi.com/1422-0067/25/2/811 Leucemia Acuta Mieloide con mutazione del gene della nucleofosmina (NPM1): dalle caratteristiche immunoistochimiche alle risposte immunologiche A PAOLINI - 2019 - morethesis.unimore.ithttps://morethesis.unimore.it/theses/available/etd-12142018-102509/ Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules A Liso , D Colau, R Benmaamar, A De Groot , W Martin - Leukemia, 2008 - nature.comhttps://www.nature.com/articles/2404887
Chemische Eigenschaften
Technische Anfrage zu: 3D-PP47138 H-CLAVEEVSLRK-OH
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.